These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 33830976)

  • 1. Angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers for COVID-19: A living systematic review of randomized clinical trials.
    Meza N; Pérez-Bracchiglione J; Pérez I; Carvajal C; Ortiz-Muñoz L; Olguín P; Rada G; Madrid E;
    Medwave; 2021 Mar; 21(2):e8105. PubMed ID: 33830976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-based therapies for COVID-19: A living, systematic review.
    Rada G; Corbalán J; Rojas P;
    Medwave; 2020 Dec; 20(11):e8079. PubMed ID: 33382060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrolides for the treatment of COVID-19: a living, systematic review.
    Verdejo C; Vergara-Merino L; Meza N; Pérez-Bracchiglione J; Carvajal-Juliá N; Madrid E; Rada G; Rojas Reyes MX
    Medwave; 2020 Dec; 20(11):e8074. PubMed ID: 33361755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin C for COVID-19: A living systematic review.
    Baladia E; Pizarro AB; Ortiz-Muñoz L; Rada G
    Medwave; 2020 Jul; 20(6):e7978. PubMed ID: 32759894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sexual transmission of SARS-CoV-2 virus and its role in the spread of COVID-19: A living systematic review protocol.
    Duarte G; Ortiz-Muñoz L; Morales MB; Acuña MP; Rada G;
    Medwave; 2020 Nov; 20(10):e8062. PubMed ID: 33361754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.
    Sharma P; Blackburn RC; Parke CL; McCullough K; Marks A; Black C
    Cochrane Database Syst Rev; 2011 Oct; (10):CD007751. PubMed ID: 21975774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood pressure reduction and clinical outcomes with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: protocol for a systematic review and meta-regression analysis.
    Batty JA; Tang M; Hall M; Ferrari R; Strauss MH; Hall AS
    Syst Rev; 2018 Aug; 7(1):131. PubMed ID: 30144828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for IgA nephropathy in children.
    Vaz de Castro PAS; Bitencourt L; Pereira BWS; Lima AQR; Hermida HS; Moreira Neto CR; Mestriner MD; Simões E Silva AC
    Pediatr Nephrol; 2022 Mar; 37(3):499-508. PubMed ID: 34686915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of angiotensin converting enzyme inhibitors versus angiotensin II receptor blockers on insulin resistance in hypertensive patients: A protocol for a systematic review and meta-analysis.
    Yao J; Gong X; Shi X; Fan S; Chen J; Chen Q
    Medicine (Baltimore); 2020 Jun; 99(24):e20674. PubMed ID: 32541513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults: A Living Systematic Review.
    Mackey K; King VJ; Gurley S; Kiefer M; Liederbauer E; Vela K; Sonnen P; Kansagara D
    Ann Intern Med; 2020 Aug; 173(3):195-203. PubMed ID: 32422062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective meta-analysis protocol on randomised trials of renin-angiotensin system inhibitors in patients with COVID-19: an initiative of the International Society of Hypertension.
    Gnanenthiran SR; Borghi C; Burger D; Charchar F; Poulter NR; Schlaich MP; Steckelings UM; Stergiou G; Tomaszewski M; Unger T; Wainford RD; Williams B; Rodgers A; Schutte AE
    BMJ Open; 2021 Feb; 11(2):e043625. PubMed ID: 33593784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on all-cause mortality, cardiovascular death, and cardiovascular events among peritoneal dialysis patients: A protocol for systematic review.
    Nochaiwong S; Ruengorn C; Mongkhon P; Thavorn K; Awiphan R; Noppakun K; Vongsanim S; Chongruksut W; Hutton B; Sood MM; Knoll GA;
    Medicine (Baltimore); 2020 Apr; 99(17):e19767. PubMed ID: 32332616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of gloves for the prevention of COVID-19 in healthy population: A living systematic review protocol.
    Morales MB; Ortiz-Muñoz L; Duarte Anselmi G; Rada G;
    Health Sci Rep; 2021 Jun; 4(2):e255. PubMed ID: 33732895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension.
    Li EC; Heran BS; Wright JM
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009096. PubMed ID: 25148386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of ACEI/ARB drugs in patients with COVID-19 combined with diabetes mellitus: A protocol for systematic review and meta-analysis of randomized controlled trials.
    Yang Y; Liu X; Liu Y; Chen Y; Tian Y; Fu X; Zhong W; Xie C
    Medicine (Baltimore); 2020 Aug; 99(35):e21723. PubMed ID: 32871892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin-Angiotensin System Inhibitors in Patients With COVID-19: A Meta-Analysis of Randomized Controlled Trials Led by the International Society of Hypertension.
    Gnanenthiran SR; Borghi C; Burger D; Caramelli B; Charchar F; Chirinos JA; Cohen JB; Cremer A; Di Tanna GL; Duvignaud A; Freilich D; Gommans DHF; Gracia-Ramos AE; Murray TA; Pelorosso F; Poulter NR; Puskarich MA; Rizas KD; Rothlin R; Schlaich MP; Schreinlecher M; Steckelings UM; Sharma A; Stergiou GS; Tignanelli CJ; Tomaszewski M; Unger T; van Kimmenade RRJ; Wainford RD; Williams B; Rodgers A; Schutte AE;
    J Am Heart Assoc; 2022 Sep; 11(17):e026143. PubMed ID: 36000426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of the pharmacological management of aortic root dilation in Marfan syndrome.
    Thakur V; Rankin KN; Hartling L; Mackie AS
    Cardiol Young; 2013 Aug; 23(4):568-81. PubMed ID: 23083542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19.
    Pan M; Vasbinder A; Anderson E; Catalan T; Shadid HR; Berlin H; Padalia K; O'Hayer P; Meloche C; Azam TU; Khaleel I; Michaud E; Blakely P; Bitar A; Huang Y; Zhao L; Pop-Busui R; Loosen SH; Chalkias A; Tacke F; Giamarellos-Bourboulis EJ; Reiser J; Eugen-Olsen J; Hayek SS;
    J Am Heart Assoc; 2021 Dec; 10(24):e023535. PubMed ID: 34889102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Mortality Among COVID-19 Patients: A Systematic Review and Meta-Analysis.
    Kashour T; Bin Abdulhak AA; Tlayjeh H; Hassett LC; Noman A; Mohsen A; Al-Mallah MH; Tleyjeh IM
    Am J Ther; 2023 Jul-Aug 01; 30(4):e336-e346. PubMed ID: 33201001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers and outcomes in patients with COVID-19: a systematic review and meta-analysis.
    Lo KB; Bhargav R; Salacup G; Pelayo J; Albano J; McCullough PA; Rangaswami J
    Expert Rev Cardiovasc Ther; 2020 Dec; 18(12):919-930. PubMed ID: 32945216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.